Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Primer in Precision Nephrology: Optimizing Outcomes in Kidney Health and Disease through Data-Driven Medicine. | Kidney360 | 2023 | 36951457 | PubTator, text mining | PubMed |
| Leveraging our common African origins to understand human evolution and health. | Cell Genom | 2023 | 36950382 | PubTator, text mining | PubMed |
| Structurally divergent and recurrently mutated regions of primate genomes. | bioRxiv | 2023 | 36945442 | PubTator, text mining | PubMed |
| The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally. | BMC Nephrol | 2023 | 36944928 | PubTator, text mining | PubMed |
| Exome-First Strategy in Adult Patients With CKD: A Cohort Study. | Kidney Int Rep | 2023 | 36938085 | PubTator, text mining | PubMed |
| Spatiotemporal expression patterns of genes coding for plasmalemmal chloride transporters and channels in neurological diseases. | Mol Brain | 2023 | 36934242 | PubTator, text mining | PubMed |
| Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. | Int J Biol Sci | 2023 | 36923931 | PubTator, text mining | PubMed |
| Inhibiting APOL1 to Treat Kidney Disease. | N Engl J Med | 2023 | 36920762 | PubTator, text mining | PubMed |
| Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. | N Engl J Med | 2023 | 36920755 | PubTator, text mining | PubMed |
| ApoM binds endotoxin contributing to neutralization and clearance by High Density Lipoprotein. | Biochem Biophys Rep | 2023 | 36915826 | PubTator, text mining | PubMed |
| The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis. | Front Immunol | 2023 | 36911713 | PubTator, text mining | PubMed |
| Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. | Int J Mol Sci | 2023 | 36902035 | PubTator, text mining | PubMed |
| Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case-control study. | Diabetol Metab Syndr | 2023 | 36899434 | PubTator, text mining | PubMed |
| [Unexpected diagnosis of nephronopthisis in the genetic study of hypertension due to histological diagnosis of benign nephroangioesclerosis evolved in a young caucasian patient]. | Hipertens Riesgo Vasc | 2023 | 36894476 | PubTator, text mining | PubMed |
| Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. | J Exp Med | 2023 | 36880831 | PubTator, text mining | PubMed |
| Low and differential polygenic score generalizability among African populations due largely to genetic diversity. | HGG Adv | 2023 | 36873096 | PubTator, text mining | PubMed |
| Addressing kidney health disparities with new national policy: the time is now. | Cardiovasc Diagn Ther | 2023 | 36864968 | PubTator, text mining | PubMed |
| Editorial: Genetics and epigenetics of chronic kidney disease. | Front Med (Lausanne) | 2023 | 36860336 | PubTator, text mining | PubMed |
| Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia. | Crit Care | 2023 | 36859478 | PubTator, text mining | PubMed |
| Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals. | EBioMedicine | 2023 | 36857859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=32